newsfilter
← Latest News
GlobeNewswire·

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

TORONTO, March 07, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ:REUN, TSX:REUN) ("Reunion" or "the Company"), a clinical-stage biopharmaceutical company committed to developing innovative and patented